Clinical Trial Update: Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating Brilacidin oral rinse for radiation-induced oral mucositis in head and neck cancer patients are reported, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Brilacidin Oral Rinse (Brilacidin)

Snippet

Sponsor: Innovation Pharmaceuticals, Inc. | Conditions: Head and Neck Neoplasms, Mucositis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-16